Makers Laboratories Limited

Equities

MAKERSL6

INE987A01010

Pharmaceuticals

Delayed Bombay S.E. 05:30:33 03/06/2024 BST 5-day change 1st Jan Change
129 INR +3.32% Intraday chart for Makers Laboratories Limited +0.27% -6.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Makers Laboratories Gets Board Nod to Sell Mumbai, India Property to Ipca Laboratories MT
Makers Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Makers Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Makers Laboratories Limited Announces the Resignation of Ms. Surbhi Sharma as Company Secretary / Compliance Officer, Effective March 13, 2024 CI
Makers Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Makers Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Makers Laboratories Gets Eurasian Economic Union RU GMP Certificate for Ophthalmic Eye Drops Manufacturing Plant MT
Makers Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Makers Laboratories Limited Appoints Surbhi Sharma as Company Secretary and Compliance Officer CI
CARE Affirms BBB+ Rating on Makers Laboratories' Bank Financing; Outlook Stable MT
Makers Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Makers Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Makers Laboratories Limited Announces Resignation of Rinku Kholakiya as Company Secretary CI
Makers Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Makers Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Makers Laboratories Limited Appoints Rinku Kholakiya as the Company Secretary, Compliance Officer CI
Makers Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Makers Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Makers Laboratories : Swings to Loss in Fiscal Q4 MT
Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Makers Laboratories : CARE Reaffirms BBB+ Rating on Makers Laboratories' Bank Facilities; Outlook Stable MT
Makers Laboratories Limited completed the acquisition of 0.002% stake in Resonance Specialties Limited for INR 0.01 million. CI
Makers Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Makers Laboratories Limited made an offer to acquire 26% stake in Resonance Specialties Limited for approximately 170 million. CI
Chart Makers Laboratories Limited
More charts
Makers Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceuticals. The Company operates through the pharmaceuticals segment. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range) and Exylin (Amoxycillin range). Its Inspira retail packs division includes acid regulatory (PPIS), anthelmintics, anti-allergic, anti-asthmatic, anti-biotics, anti-diabetics, anti-diarrheal, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensives, and others. Its Experia bulk packs division includes amoxycillin 250 mg capsules, betamethasone 0.5 mg tablets, cetirizine HCL 10 mg tablets, chloramphenicol capsules 250 mg, chloroquine phosphate 250 mg tablets, chlorpheniramine maleate 4 mg tablets, ciprofloxacin hydrochloride 250 mg tablets, and others.
More about the company
  1. Stock Market
  2. Equities
  3. MAKERSL6 Stock
  4. News Makers Laboratories Limited
  5. Makers Laboratories : CARE Reaffirms BBB+ Rating on Makers Laboratories' Bank Facilities; Outlook Stable
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW